CCK-8 assay indicated over-expression of CCNE2 (CCNE2 (+)) promoted the proliferation of glioma U87 and U251 cells compared with CCNE2 (+)-NC group (Figure 5A; P < 0.05). The gene discussed is CCNE2; the disease is central nervous system cancer.